Achieve Life Sciences (ACHV) Debt by Year
Achieve Life Sciences, Inc. carried $11.2M in long-term debt against $20.9M in cash and equivalents at the end of fiscal year 2025. Long-term debt rose 13.7% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Achieve Life Sciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ACHV Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $11.2M+13.7% | $9.8M | N/A | N/A | $14.9M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $20.9M+64.1% | $12.8M-18.0% | $15.5M-37.2% | $24.8M-42.4% | $43.0M+20.0% | $35.9M+115.2% | $16.7M+75.1% | $9.5M+80.1% | $5.3M+35126.7% | $15K-77.6% | $67K-99.8% | $27.9M+91.2% | $14.6M-19.3% | $18.1M-36.6% | $28.5M |
ACHV Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $7.5M-13.9% | $9.3M+7.7% | $11.2M+13.7% | $8.7M-11.7% | $8.7M-1.7% | $8.7M | $9.8M | $9.8M-39.3% | $8.8M-44.0% | N/A | N/A | $16.2M+2.7% |
| Cash & Equivalents | $48.0M-7.5% | $28.1M+115.7% | $20.9M+64.1% | $31.9M+234.6% | $51.9M+251.5% | $13.0M-80.4% | $12.8M-18.0% | $9.5M-52.1% | $14.8M-41.1% | $66.4M+302.1% | $15.5M-37.2% | $19.9M+9.5% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Achieve Life Sciences, Inc. financials
Frequently Asked Questions
What was Achieve Life Sciences, Inc.'s long-term debt in fiscal year 2025?
Achieve Life Sciences, Inc. carried $11.2M in long-term debt against $20.9M in cash and equivalents at the end of fiscal year 2025.
How fast is Achieve Life Sciences, Inc.'s long-term debt growing?
Achieve Life Sciences, Inc. (ACHV) long-term debt rose by 13.7% year over year, from $9.8M to $11.2M in fiscal year 2025.
What was Achieve Life Sciences, Inc.'s long-term debt in the most recent quarter?
Achieve Life Sciences, Inc. (ACHV) reported $7.5M in long-term debt in Q2 2026. This represents a decrease of 13.9% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Achieve Life Sciences, Inc. (ACHV) reported on that line in every period on record.